FDA grants 510(k) clearance to Emboliner system for TAVR procedures
The FDA's decision follows a clinical assessment of the Emboliner, including the PROTECT H2H IDE study.
Educating the medical device manufacturing industry since 2002.
The FDA's decision follows a clinical assessment of the Emboliner, including the PROTECT H2H IDE study.